
Matthew Yglesias @mattyglesias
It's cool that the NIH hasn't updated its Covid-19 treatment guidelines for Fluvoxamine since April when a big study showing large positive results was published in the Lancet in October. https://t.co/eua72pMj3D — PolitiTweet.org